| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Taysha Gene Therapies, Inc. (TSHA) has 8 insiders with recent SEC Form 4 filings, including 11 buys and 13 sells. TSHA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 2.84M | $19.35M | - | |
| CFO | 1.44M | $9.82M | - | |
| Dir | 1.16M | $7.87M | - | |
| Pres | 1.12M | $7.61M | - | |
| CEO | 648.0K | $4.41M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 22, 2022 | Alam Kamran83 | Chief Financial Officer | Sell | 28,675 | $3.70 | $105,999.12 | -3.3% | -35.3% | -42.0% | |
| Jul 6, 2022 | Prasad Suyash90 | CMO And Head Of R&D | Sell | 12,861 | $3.70 | $47,649.79 | -1.2% | -45.5% | -82.5% | |
| Jul 1, 2022 | Prasad Suyash90 | CMO And Head Of R&D | Sell | 50,139 | $3.65 | $183,080.87 | -2.9% | -41.4% | -80.8% | |
| Feb 3, 2022 | Manning Paul B53 | Director, 10% Owner | Buy | 201,602 | $7.80 | $1,571,809.68 | +4.8% | -45.1% | -84.4% | |
| Feb 2, 2022 | Nagendran Sukumar49 | Director | Buy | 10,000 | $8.01 | $80,100.00 | +52.0% | -44.0% | -84.6% | |
| Feb 2, 2022 | Donenberg Phillip B. | Director | Buy | 3,000 | $7.78 | $23,340.00 | New | -44.0% | -84.6% | |
| Nov 24, 2021 | Manning Paul B53 | Director, 10% Owner | Buy | 2,202 | $13.19 | $29,044.38 | +6.9% | -54.3% | -82.6% | |
| Nov 23, 2021 | Session R.A. II | President And CEO | Buy | 42,518 | $12.44 | $529,102.40 | +0.2% | -52.3% | -81.8% | |
| Nov 23, 2021 | Manning Paul B53 | Director, 10% Owner | Buy | 20,000 | $12.54 | $250,800.00 | +166.7% | -52.3% | -81.8% | |
| Aug 20, 2021 | Alam Kamran83 | Chief Financial Officer | Sell | 33,000 | $16.88 | $557,022.56 | -2.1% | -18.5% | -77.9% |